Table 3.

Difference in estimated VS probability for each comorbidity archetype minus the archetype with no comorbidities at the given time point with 95% CI

Comorbidity archetypea	Time pointb	Difference	95% CI	p
Stimulant use only	−12 months	−0.037	−0.067, −0.007	.015
Housing instability only	−12 months	−0.084	−0.114, −0.054	<.001
High PHQ-9	−12 months	−0.007	−0.026, 0.013	.500
All comorbidities	−12 months	−0.132	−0.174, −0.091	<.001
Stimulant use only	−0 months	−0.067	−0.091, −0.044	<.001
Housing instability only	−0 months	0.042	0.017, 0.067	.001
High PHQ-9	−0 months	−0.014	−0.031, 0.002	.091
All comorbidities	−0 months	−0.043	−0.075, −0.010	.011
Stimulant use only	+0 months	−0.078	−0.106, −0.051	<.001
Housing instability only	+0 months	−0.021	−0.047, 0.005	.118
High PHQ-9	+0 months	−0.041	−0.059, −0.024	<.001
All comorbidities	+0 months	−0.144	−0.181, −0.107	<.001
Stimulant use only	6 months	−0.070	−0.089, −0.051	<.001
Housing instability only	6 months	−0.080	−0.098, −0.062	<.001
High PHQ-9	6 months	−0.023	−0.034, −0.012	<.001
All comorbidities	6 months	−0.195	−0.223, −0.166	<.001
Stimulant use only	36 months	−0.074	−0.096, −0.053	<.001
Housing instability only	36 months	−0.068	−0.089, −0.048	<.001
High PHQ-9	36 months	0.011	−0.001, 0.023	.083
All comorbidities	36 months	−0.139	−0.170, −0.109	<.001

^aThe reference archetype is those with no comorbidities

^b−0 months denotes time immediately before MCC enrollment, and +0 months denotes the time right after MCC enrollment.